Cargando…

Challenges in Commercializing Biomimetic Membranes

The discovery of selective water channel proteins—aquaporins—has prompted growing interest in using these proteins, as the building blocks for designing new types of membranes. However, as with any other new and potentially disruptive technology, barriers for successful market entry exist. One categ...

Descripción completa

Detalles Bibliográficos
Autores principales: Perry, Mark, Madsen, Steen Ulrik, Jørgensen, Tine, Braekevelt, Sylvie, Lauritzen, Karsten, Hélix-Nielsen, Claus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4704006/
https://www.ncbi.nlm.nih.gov/pubmed/26556379
http://dx.doi.org/10.3390/membranes5040685
_version_ 1782408825131761664
author Perry, Mark
Madsen, Steen Ulrik
Jørgensen, Tine
Braekevelt, Sylvie
Lauritzen, Karsten
Hélix-Nielsen, Claus
author_facet Perry, Mark
Madsen, Steen Ulrik
Jørgensen, Tine
Braekevelt, Sylvie
Lauritzen, Karsten
Hélix-Nielsen, Claus
author_sort Perry, Mark
collection PubMed
description The discovery of selective water channel proteins—aquaporins—has prompted growing interest in using these proteins, as the building blocks for designing new types of membranes. However, as with any other new and potentially disruptive technology, barriers for successful market entry exist. One category includes customer-related barriers, which can be influenced to some extent. Another category includes market-technical-related barriers, which can be very difficult to overcome by an organization/company aiming at successfully introducing their innovation on the market—in particular if both the organization and the technology are at early stages. Often, one faces barriers from both these categories at the same time, which makes it necessary to gain insight of the particular market when introducing a new innovative product. In this review we present the basic concepts and discuss some of these barriers and challenges associated with introducing biomimetic aquaporin membranes. These include technical issues in membrane production and product testing. Then we discuss possible business models for introducing new technologies in general, followed by a presentation of beach-head market segments relevant for biomimetic aquaporin membranes.
format Online
Article
Text
id pubmed-4704006
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-47040062016-01-21 Challenges in Commercializing Biomimetic Membranes Perry, Mark Madsen, Steen Ulrik Jørgensen, Tine Braekevelt, Sylvie Lauritzen, Karsten Hélix-Nielsen, Claus Membranes (Basel) Review The discovery of selective water channel proteins—aquaporins—has prompted growing interest in using these proteins, as the building blocks for designing new types of membranes. However, as with any other new and potentially disruptive technology, barriers for successful market entry exist. One category includes customer-related barriers, which can be influenced to some extent. Another category includes market-technical-related barriers, which can be very difficult to overcome by an organization/company aiming at successfully introducing their innovation on the market—in particular if both the organization and the technology are at early stages. Often, one faces barriers from both these categories at the same time, which makes it necessary to gain insight of the particular market when introducing a new innovative product. In this review we present the basic concepts and discuss some of these barriers and challenges associated with introducing biomimetic aquaporin membranes. These include technical issues in membrane production and product testing. Then we discuss possible business models for introducing new technologies in general, followed by a presentation of beach-head market segments relevant for biomimetic aquaporin membranes. MDPI 2015-11-05 /pmc/articles/PMC4704006/ /pubmed/26556379 http://dx.doi.org/10.3390/membranes5040685 Text en © 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Perry, Mark
Madsen, Steen Ulrik
Jørgensen, Tine
Braekevelt, Sylvie
Lauritzen, Karsten
Hélix-Nielsen, Claus
Challenges in Commercializing Biomimetic Membranes
title Challenges in Commercializing Biomimetic Membranes
title_full Challenges in Commercializing Biomimetic Membranes
title_fullStr Challenges in Commercializing Biomimetic Membranes
title_full_unstemmed Challenges in Commercializing Biomimetic Membranes
title_short Challenges in Commercializing Biomimetic Membranes
title_sort challenges in commercializing biomimetic membranes
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4704006/
https://www.ncbi.nlm.nih.gov/pubmed/26556379
http://dx.doi.org/10.3390/membranes5040685
work_keys_str_mv AT perrymark challengesincommercializingbiomimeticmembranes
AT madsensteenulrik challengesincommercializingbiomimeticmembranes
AT jørgensentine challengesincommercializingbiomimeticmembranes
AT braekeveltsylvie challengesincommercializingbiomimeticmembranes
AT lauritzenkarsten challengesincommercializingbiomimeticmembranes
AT helixnielsenclaus challengesincommercializingbiomimeticmembranes